Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer.

R, Khalil, Green RJ, Sivakumar K, Varandani P, Bharadwaj S, Mohapatra SS, and Mohapatra S. 2023. “Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer.”. Cancers (Basel). 2023 Jun 7;15(12):3089. Doi: 10.3390/Cancers15123089. PMID: 37370701; PMCID: PMC10295988.
Last updated on 02/14/2025